Antigenicity and immunogenicity of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b.
about
Phase I clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b in human adult volunteers.Direct targeted glycation of the free sulfhydryl group of cysteine residue (Cys-34) of BSA. Mapping of the glycation sites of the anti-tumor Thomsen-Friedenreich neoglycoconjugate vaccine prepared by Michael addition reaction.Preclinical evaluation of a Haemophilus influenzae type b conjugate vaccine process intended for technology transferIdentification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14.Carbohydrate vaccines: developing sweet solutions to sticky situations?The promise of glycomics, glycan arrays and carbohydrate-based vaccines.Discovery and design of carbohydrate-based therapeutics.An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity.6-O-Branched Oligo-β-glucan-Based Antifungal Glycoconjugate Vaccines.Influence of the Co-Administration of Heptavalent Conjugate Vaccine PCV7-TT on the Immunological Response Elicited by VA-MENGOC-BC® and Heberpenta®-L in Rabbits.A modular synthetic route to size-defined immunogenic Haemophilus influenzae b antigens is key to the identification of an octasaccharide lead vaccine candidate.
P2860
Q35023397-9FFF49A4-B500-4AEE-A708-04B836A891B4Q35492743-E633BFB2-6034-4611-AA3D-46DB2B4A0E2DQ35498252-662D9E0A-1800-4C6F-B855-2967D14B957DQ36898518-1B1B49D8-5384-4B60-876B-9C361FD00F02Q37426039-77B6FDEF-A03F-4965-8539-61EC4815CAC8Q37689188-07547E75-1BA5-44F8-9B95-28900C713759Q38029137-7C743162-A04B-443B-BAFD-C253B840D0A0Q39093233-3969B64F-A5D4-41C8-9172-69F54B2D9B47Q40541300-4362685A-BF1B-4985-9C13-6A2F3D7A041AQ47401970-E7FCE6A5-17B7-4012-8BA3-EC17BA289947Q52804669-C819B9C0-188E-47AB-9F13-4C6573AF654E
P2860
Antigenicity and immunogenicity of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antigenicity and immunogenicit ...... Haemophilus influenzae type b.
@en
Antigenicity and immunogenicit ...... Haemophilus influenzae type b.
@nl
type
label
Antigenicity and immunogenicit ...... Haemophilus influenzae type b.
@en
Antigenicity and immunogenicit ...... Haemophilus influenzae type b.
@nl
prefLabel
Antigenicity and immunogenicit ...... Haemophilus influenzae type b.
@en
Antigenicity and immunogenicit ...... Haemophilus influenzae type b.
@nl
P2093
P2860
P1476
Antigenicity and immunogenicit ...... Haemophilus influenzae type b
@en
P2093
Alexis Musacchio
Arlene Rodriguez
Eugenio Hardy
Fatme Mawas
Félix Cardoso
Ibis Hernández
Ignacio Figueroa
Janoi Chang
Karelia Cosme
Lazaro Heynngnezz
P2860
P304
P356
10.1128/IAI.72.12.7115-7123.2004
P407
P577
2004-12-01T00:00:00Z